Virusbank vision

The VirusBank Platform is a test platform that combines a collection of viruses with a toolbox of cellular and animal infection models available for partnering.

We aim to facilitate the development of preventive and therapeutic strategies to efficiently control future epidemics/pandemics.

Virusbank vision

The VirusBank Platform is a test platform that combines a collection of viruses with a toolbox of cellular and animal infection models available for partnering.

We aim to facilitate the development of preventive and therapeutic strategies to efficiently control future epidemics/pandemics.

VirusBank Platform Story

It is not a matter of whether, but rather of when the next epidemic/pandemic will appear
The National Pact for strategic investments and the Belgian Federal Government Agreement (including the recovery plan) of September 30th, 2020, stipulate the need for investment in an entity that congregates the activities of setting up a virus bank and using it for research to advance the development of pharmaceutical solutions. At the KU Leuven, Johan Neyts (Professor of Virology at the Rega Institute) and Dr Patrick Chaltin (Director of the Centre for Drug Design & Development CD3) responded to Belgium’s need to create a ‘Biopreparedness and Anti-Infectives Unit’ by submitting in 2021 a proposal.
Capitalizing on Belgium’s world-class virology expertise and research infrastructure will drive success against the next epidemic/pandemic
The initial proposal was further developed in 2022 into the concept of the ‘VirusBank Platform’, a research organization fully equipped to perform all of research on viruses of high epidemic or pandemic concern. The proposed platform combines and centralizes relevant dedicated viral expertise with a highly-secured research infrastructure at KU Leuven – unique in Belgium and Europe – allowing the automated manipulation and high-throughput handling of pathogenic viruses (with Caps-It) addressing Belgium’s pandemic preparedness objectives. The VirusBank Platform application was granted 20 million € funding from the Belgian Federal Government.
Creating partnerships will accelerate epidemic/pandemic preparedness
With an expanding strategic collection of viruses and a toolbox of viral infection assays to offer, we welcome different types of partnership and aim to be an accelerator for the discovery and development of prophylactic and therapeutic strategies against viruses posing a potential epidemic/pandemic threat. The VirusBank Platform will work closely with the Federal Health Agencies, Sciensano and Belspo, to ensure that the available research capacity is used to the maximum.
LATEST PRESS

VirusBank Platform News

16 January 2023
CEPI

CEPI, Belgian universities to partner to enhance global pandemic preparedness

12 September 2022
NextGenBelgium

Créer une plateforme dédiée aux virus épidémiques et pandémiques

9 September 2022
The Brussels Times

Belgium earmarks €20 million for virus bank platform